Sun Pharmaceutical, India's largest pharmaceutical company by market capitalisation, has slipped behind the Sensex and Nifty in 2025. So far this year, the stock has declined about 8% even as both benchmark indices have risen close to 9%. This is the first time in six years that the company has shown underperformance. The Nifty Pharma index slipped 3.5% this year.